Recent research has illuminated how genetic makeup can significantly influence the effectiveness of popular weight-loss medications, such as Wegovy and Mounjaro. A study published in the journal Nature highlights that individuals with specific genetic variants related to appetite regulation and digestion may experience greater weight loss when using these drugs. This new understanding could help explain the varied results that patients see and could inform future treatment approaches.
Genetic Variants and Weight Loss
The study involved 15,000 participants who had previously undergone genetic testing through the company 23andMe. It found that those carrying certain genetic variants lost more weight compared to those without these variants. On average, participants in the study shed 11.7% of their body weight over approximately eight months. Some individuals achieved remarkable results, losing up to 30% of their weight, while others saw little to no change.
Professor Ruth Loos from the University of Copenhagen, who contributed to the research, noted, “The study identified a genetic variant associated with weight loss, which was also connected to nausea.” Those with this variant tended to lose an additional average of 0.76 kg (1.6 lbs). Importantly, individuals possessing two copies of the gene could potentially double their weight loss.
This particular genetic variant is more prevalent among individuals of European descent, with 64% carrying one copy and 16% having two. In contrast, only 7% of African Americans carry this gene variant, which highlights the need for a nuanced understanding of how genetic factors can affect treatment outcomes.
Side Effects and Their Genetic Links
The research also uncovered another genetic variant possibly linked to adverse side effects, such as nausea and vomiting, particularly with the use of tirzepatide (Mounjaro). It suggests that up to 1% of users may experience severe vomiting, nearly 15 times more intense than typical side effects associated with the drug.
While the genetic influence on weight loss is modest, Professor Loos emphasised its relevance, stating, “The genetic effect is similar to other factors – not trivial but also not the only consideration.”
Other Influential Factors
Aside from genetics, various other factors play a crucial role in the effectiveness of weight-loss medications. Research indicates that behavioural aspects, such as diet and exercise, significantly impact outcomes. Women are reportedly more than twice as likely to achieve a 15% weight loss on Mounjaro compared to men. Younger individuals and those of white or Asian ethnicity also appear to have better success rates, although the reasons for this disparity remain unclear.
Furthermore, the type of medication, dosage, and the duration of treatment can all affect weight loss results. Experts believe that integrating genetic information with other patient characteristics may one day lead to “precision medicine,” guiding the selection of weight-loss drugs tailored to individual profiles.
The Road Ahead
Despite the promising findings, Professor Naveed Sattar, a metabolic health expert at the University of Glasgow, cautioned that these insights are still far from being integrated into standard clinical practice. “We need more robust trial data to better define the balance of benefits and harms associated with these and other emerging therapies,” he remarked.
As the number of people seeking weight-loss treatments continues to rise — with at least 1.6 million in the UK attempting weight-loss drugs in the past year — understanding the underlying factors influencing drug effectiveness becomes increasingly vital.
Why it Matters
The implications of this research extend beyond individual weight-loss journeys. By understanding the genetic and other variables influencing the success of weight-loss medications, healthcare professionals could devise more effective treatment strategies tailored to individual needs. This could lead to improved health outcomes and a significant reduction in obesity-related health issues, ultimately fostering a healthier society. As the landscape of obesity treatment evolves, integrating genetic insights may pave the way for a more personalised approach to managing weight and health.
